Gabriella Costabile

Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?

Gemma Conte, Gabriella Costabile, Domizia Baldassi et al. · ACS Applied Materials & Interfaces · 2022 · 97 citations · Full text

Pharmacy, Biotechnology, Pharmaceutics +17

Toward Repositioning Niclosamide for Antivirulence Therapy of <i>Pseudomonas aeruginosa</i> Lung Infections: Development of Inhalable Formulations through Nanosuspension Technology

Gabriella Costabile, Ivana d’Angelo, Giordano Rampioni et al. · Molecular Pharmaceutics · 2015 · 82 citations

Pharmacy, Infectious Diseases, Pharmaceutics +17

Hybrid Lipid/Polymer Nanoparticles for Pulmonary Delivery of siRNA: Development and Fate Upon <i>In Vitro</i> Deposition on the Human Epithelial Airway Barrier

Ivana d’Angelo, Gabriella Costabile, Estelle Durantie et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2017 · 72 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles

Tobias W. M. Keil, Daniel P. Feldmann, Gabriella Costabile et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2019 · 58 citations · Full text

Pharmacy, Biotechnology, Materials Science +12

Evaluation of β-Sitosterol Loaded PLGA and PEG-PLA Nanoparticles for Effective Treatment of Breast Cancer: Preparation, Physicochemical Characterization, and Antitumor Activity

Moses Andima, Gabriella Costabile, Lorenz Isert et al. · Pharmaceutics · 2018 · 55 citations · Full text

Pharmacy, Oncology, Pharmacology +17